Nonalcoholic fatty liver disease (NAFLD) is a condition wherein the liver stores excess fat. Nonalcoholic steatohepatitis (NASH) is one type of NAFLD. 肥満と 2 型糖尿病はNAFLD発症のリスクが高いようです。In recent years, NASH and NAFLD have been renamed MASH (metabolic dysfunction-associated steatohepatitis) and MASLD (metabolic dysfunction-associated … Continued
An novel single dose regimen of tremelimumab combined with durvalumab could be a way to treat unresectable hepatocellular carcinoma. In this recently published Clinical Cancer Research study, co-authored by Certara’s Rajesh Krishna, the findings reveal that overall survival was longer for patients given this drug regimen.
抗体薬物複合体（ADC）は、腫瘍細胞を消滅させるユニークな方法であり、単独療法であれ併用療法であれ、腫瘍学において十分に利用されていない免疫治療薬の選択肢です。ADCの最初のFDA承認は2011年でした... ADC development is inherently challenging because it … Continued
